Initial trials suggest that this peptide – a dual stimulator of GLP-1 and GIP receptors – offers a significant breakthrough in metabolic reduction therapies. Unlike existing treatments , Retatrutide seems to modify food intake and calorie expenditure via multiple routes. While further examinatio